Clinical Trial Update: XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors [Phase 3]

View source ↗

Summary

Phase 3 results update for XERECEPT (human corticotropin-releasing factor) in patients requiring dexamethasone to treat edema associated with brain tumors. Resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Edema
• Brain Tumor

Drugs mentioned

• XERECEPT (human corticotropin-releasing factor)

Snippet

Sponsor: Celtic Pharma Development Services | Conditions: Brain Edema, Brain Tumor | Phase 3 | Status: COMPLETED | Results posted: 2014-08-13